European Renal Replacement Therapy Markets

European Renal Replacement Therapy Markets

 

RELEASE DATE
27-Jun-2005
REGION
Europe
Research Code: B541-01-00-00-00
SKU: HC01088-EU-MR_05132
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC01088-EU-MR_05132

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

Failure of the kidneys could prove fatal if it were not for the possibility of kidney transplantation or the commencement of renal replacement therapy, RRT.
In 2004, more than 100,000 acute renal failure patients and almost 200,000 end-stage renal disease patients received RRT. Interestingly, although renal failure patients only account for a minimal per cent of the total patients treated across the western European regions, the per cent of healthcare payments expended on these patients is much greater.
This research service takes a strategic look at possible tactics to enable companies in the RRT markets to realise the potential revenues for the European renal replacement therapy markets of 2011.

Table of Contents

Executive Summary

  • Executive Summary for the European Renal Replacement Therapy Market

Introduction

  • Research Scope and Methodology
  • Objectives
  • Market Segmentation

Glossary of Terms

  • Key Definitions
  • Key Populations Statistics by Country

Identification of Challenges Facing the European Renal Replacement Therapy Market

  • Overview
  • Industry Challenges
  • Market Drivers
  • Market Restraints
  • Life Cycle Analysis

European Acute Renal Failure Therapy Market

  • Market Engineering Measurements
  • Market Forecast

European End Stage Renal Disease Therapy Market

  • Market Engineering Measurements
  • Market Forecast

Pricing Trends

  • Pricing Trends

Renal Replacement Therapy Market

End Stage Renal Disease Therapy Market

European Acute Renal Failure Therapy Equipment Market

European End Stage Renal Disease Therapy Market; Conventional Haemodialysis Equipment Market

European End Stage Renal Disease Therapy Market; Home Based Haemodialysis Equipment Market

European End Stage Renal Disease Therapy Market; Alternative Site, Self Care, Haemodialysis Equipment Market

  • Overview
  • Market Drivers
  • Market Restraint
  • Market Challenges

Competitor Profiling

European Market Breakdown

Company Positioning

Market Potential

Competitive Frameworks

Renal Replacement Therapy Market

End Stage Renal Disease; Conventional Haemodialysis Therapy Market

End Stage Renal Disease; Alternative Site and Home based Self Care Haemodialysis Therapy Market

Pricing Pressures

Databases on Healthcare Infrastructure

Database on Healthcare Expenditure

Database on Medical Staff

Databases on Diabetes

Database on Transplants and Surgery

Databases on Others

Failure of the kidneys could prove fatal if it were not for the possibility of kidney transplantation or the commencement of renal replacement therapy, RRT. In 2004, more than 100,000 acute renal failure patients and almost 200,000 end-stage renal disease patients received RRT. Interestingly, although renal failure patients only account for a minimal per cent of the total patients treated across the western European regions, the per cent of healthcare payments expended on these patients is much greater. This research service takes a strategic look at possible tactics to enable companies in the RRT markets to realise the potential revenues for the European renal replacement therapy markets of 2011.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number B541-01-00-00-00
Is Prebook No